Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 41.3 Million Yuan Net Loss in First Quarter of 2022

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 41.3 million yuan in the first quarter of 2022, narrowing 37.7% year-on-year.

Meanwhile, the company posted 191.3 million yuan in revenue, down 75.4% year-on-year.

At the end of the reporting period, it had 7.5 billion yuan in total assets and 3 billion yuan in total liabilities, with a liability-to-asset ratio of 39.8%.